M W Carney, B F Sheffield. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Basal Ganglia Diseases/chemically inducedBipolar Disorder/chemically inducedCatatonia/drug therapyDepression/chemically inducedFemaleFluphenazine/therapeutic useHospitalizationHumansHyperbilirubinemia, Hereditary/complicationsInjections, IntramuscularLong-Term CareMaleNeurasthenia/chemically inducedOutpatient Clinics, HospitalPiperazines/administration & dosagePiperazines/adverse effectsPiperazines/therapeutic usePsychiatric Status Rating ScalesRecurrenceSchizophrenia/complicationsSchizophrenia/drug therapySchizophrenia, Disorganized/drug therapySchizophrenia, Paranoid/drug therapyThioxanthenes/administration & dosageThioxanthenes/adverse effectsThioxanthenes/therapeutic useTime FactorsTranquilizing Agents/administration & dosageTranquilizing Agents/adverse effectsTranquilizing Agents/therapeutic use
Substances: See more » PiperazinesThioxanthenesTranquilizing AgentsFluphenazine
Year: 1973 PMID: 4203952 DOI: 10.1185/03007997309111704
Source DB: PubMed Journal: Curr Med Res Opin ISSN: 0300-7995 Impact factor: 2.580